STEMINA BIOMARKER DISCOVERY, INC.

Basic Information

504 S. Rosa Road
MADISON, WI, 53719-1256

Company Profile

n/a

Additional Details

Field Value
DUNS: 794516695
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: 11


  1. Identification of Biomarkers of Cardiotoxicity using Metabolomics of Human Pluripotent Stem Cell-Derived Cardiomyocytes

    Amount: $742,776.00

    DESCRIPTION provided by applicant Identification of Biomarkers of Cardiotoxicity using Metabolomics of Human Pluripotent Stem Cell Derived Cardiomyocytes Project Summary Abstract Cardiac safety is ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of HealthDepartment of Health and Human Services
  2. A Metabolism-Based Test to Diagnose Autism Spectrum Disorder and its Subtypes in Early Childhood

    Amount: $892,872.00

    DESCRIPTION provided by applicant Autism spectrum disorder ASD is now diagnosed in of children with recent reports citing as many as in children in the United States The average age o ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of HealthDepartment of Health and Human Services
  3. Identification of Biomarkers of Cardiotoxicity using Metabolomics of Human Plurip

    Amount: $146,666.00

    DESCRIPTION (provided by applicant): Cardiotoxicity, as a result of adverse drug effects, is a serious problem that has yet to be effectively screened prior to patient exposure. Cardiac safety is one ...

    SBIR Phase I 2012 Department of Health and Human Services
  4. SBIR Phase II: Metabolomics of Human Embryonic Stem Cells to Predict Teratogenicity: An Alternative Developmental Toxicity Model

    Amount: $500,000.00

    This Small Business Innovation Research (SBIR) Phase II project will fund a continuation of breakthrough research, development and commercialization of an in vitro assay to help prevent birth defects. ...

    SBIR Phase II 2011 National Science Foundation
  5. Not Available

    Amount: $999,936.00

    Brain tumor stem cells (BTSCs) are a subset population within tumors that are widely believed to be responsible for tumor recurrence, due to their ability to self-renew, differentiate, migrate, and i ...

    SBIR Phase II 2010 Department of Health and Human Services
  6. SBIR Phase I: Metabolomics of Human Embryonic Stem Cells to Predict Teratogenicity: An Alternative Developmental Toxicity Model

    Amount: $149,255.00

    This Small Business Innovation Research (SBIR) Phase I project proposes to develop a highly predictive model for assessing the potential of compounds to cause birth defects in the developing human emb ...

    SBIR Phase I 2009 National Science Foundation
  7. SBIR TOPIC 245 "PREDICTIVE EFFICACY SCREENING IN CANCER STEM CELLS USING METABOLO

    Amount: $149,528.00

    Cancer stem cells (CSCs) are a critical tumor subpopulation that may cause local recurrences that plague patients with advanced solid malignancies, even after maximal therapeutic efforts. CSCs can sel ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government